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Research
Previous studies of traffic-related pollution 
have observed associations between motor 
vehicle pollution and an array of adverse 
health outcomes, including respiratory and 
cardiovascular diseases (White et al. 2005). 
The immune system is a hypothesized bio-
logic mediator of such health effects (Brook 
et al. 2004; Devalia et al. 1997). The strongest 
evidence of an association between air pol-
lution and immune status in adults comes 
from studies of serum levels of C-reactive 
protein (CRP)—an acute-phase reactant and 
well-established marker of inflammation—
in which indicators of increased air pollu-
tion were associated with higher CRP levels 
(Delfino et al. 2008; Diez Roux et al. 2006; 
Dubowsky et al. 2006; Peters et al. 2001; Pope 
et al. 2004; Riediker et al. 2004; Ruckerl et al. 
2006; Seaton et al. 1999; Yue et al. 2007; 
Zeka et al. 2006). The hypothesis that air pol-
lution may cause immune-suppressive effects 
is supported by animal studies demonstrat-
ing increased susceptibility to infection with 
diesel exhaust exposure [U.S. Environmental 
Protection Agency (EPA) 2002] and epide-
miologic studies showing increases in hos-
pital admissions for respiratory infections 
with increases in nitrogen dioxide among the 
general population (Fusco et al. 2001; Lin 
et al. 2005). None of the previous studies of 
air pollution and immune function in adults 
has directly evaluated exposure to traffic.
We studied the association between traffic-
related pollution and biomarkers of systemic 
inflammation and cellular immunity in the 
Puget Sound region of Washington State. 
Because traffic-related pollutants, such as nitro-
gen dioxide and ultrafine particles, are high 
near major roadways and then decay exponen-
tially over a short distance (Lebret et al. 2000; 
Roorda-Knape et al. 1999; Zhu et al. 2002), 
we assessed exposure according to residential 
proximity to major roads. Our study popula-
tion consisted of overweight, postmenopausal 
women, a group that may be particularly vul-
nerable to air pollution–related health effects, 
based on results of previous studies showing 
the strongest air pollution associations with 
inflammatory markers among obese persons 
(Dubowsky et al. 2006; Zeka et al. 2006).
We investigated three markers of systemic 
inflammation—CRP, serum amyloid A (SAA), 
and interleukin-6 (IL-6)—and two measures 
of cellular immunity, natural killer (NK) cell 
cytotoxicity and T-lymphocyte proliferation. 
CRP is a recognized predictor of cardiovascular 
disease, and SAA and IL-6 may also predict 
inflammation-related diseases (Ershler 1993; 
Johnson et al. 2004; Kritchevsky et al. 2005; 
Yeh and Willerson 2003). The NK cyto-
toxicity assay measures the ability of NK cells 
to kill cancerous target cells (Albers et al. 2005; 
Vedhara et al. 1999). Low levels of NK cyto-
toxicity are believed to reflect a defect in the 
natural immune response and may predict risk 
of future adverse health events, including infec-
tion and cancer (Imai et al. 2000; Levy et al. 
1991; Mizutani et al. 1996; Ogata et al. 2001). 
Higher levels of in vitro lymphocyte prolifera-
tion are believed to reflect a more effective 
immune response (Albers et al. 2005; Imai 
et al. 2000; Levy et al. 1991; Ogata et al. 2001; 
Vedhara et al. 1999).
Materials and Methods
Study design. We conducted a cross-sectional 
analysis of the associations between traffic-
related pollution and a set of five immune 
assays using data from the baseline visit of 
an intervention trial of exercise conducted 
at the Fred Hutchinson Cancer Research 
Center (FHCRC) (McTiernan et al. 1999). 
In our study procedures, we complied with all 
applicable U.S. requirements (including the 
FHCRC and University of Washington insti-
tutional review boards), and all women gave 
written informed consent before participation 
in the study.
Study population. Women were recruited 
from the greater Seattle area from 1998 to 
2000 to participate in the Physical Activity for 
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Ba c k g r o u n d: Traffic-related air pollution has been associated with adverse health outcomes, and 
the immune system may be a biologic mediator of health effects.
oBjectives: We analyzed associations between living near major roads and immune status as meas-
ured by five immune assays. We hypothesized that living near a freeway, arterial, or truck route 
would be associated with increased inflammation and decreased immune function.
Me t h o d s : We used a geographic information system (GIS) to determine residential proximity to major 
roads among 115 postmenopausal, overweight women in the greater Seattle, Washington (USA), area 
whose immunity was assessed at the baseline visit of an exercise intervention trial. We evaluated three 
inflammatory markers (C-reactive protein, serum amyloid A, and interleukin-6) and two functional 
assays of cellular immunity [natural killer (NK) cell cytotoxicity and T-lymphocyte proliferation].
re s u l t s: Women living within 150 m of arterial roads had 21% lower NK cytotoxicity compared 
with women who lived farther from an arterial [mean cytotoxicity, 19.5%; 95% confidence interval 
(CI), 15.6–23.5%; vs. mean cytotoxicity, 24.8%; 95% CI, 22.0–27.5%], after adjustment for both 
individual-level and census tract–level demographic characteristics. This association was limited to 
women who reported exercising near traffic. Fewer women lived near freeways and truck routes. 
Markers of inflammation and lymphocyte proliferation did not consistently differ according to 
proximity to major roads.
co n c l u s i o n s: If the observed association between residential proximity to traffic and decreased NK 
cytotoxicity is confirmed in other populations, our results may have implications for local land use policy.
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Total Health study, a 12-month randomized 
controlled intervention trial comparing the 
effects of a moderate-intensity exercise inter-
vention versus a stretching control program on 
endogenous sex hormones in postmenopausal 
women (McTiernan et al. 1999). Subjects in a 
substudy of immune function (n = 115) were 
women who also met criteria for measure  ment 
of immunologic outcomes. Women were 
50–75 years of age, were nonsmokers, con-
sumed fewer than two alcohol drinks per day, 
were sedentary, were overweight or obese 
[body mass index (BMI) ≥ 25.0; or between 
24.0 and 24.9 with percentage body fat 
> 33%], were post  menopausal and not taking 
hormone replacement therapy in the preced-
ing 6 months, and had no history of invasive 
cancer, diabetes, cardiovascular disease, or 
asthma; additional eligibility criteria have 
been published previously (McTiernan et al. 
1999). Women in the substudy of immune 
function were eligible if they had no current 
serious allergies, were not regular (two or 
more times/week) users of aspirin or other 
nonsteroidal anti-inflammatory medications, 
and were not using corticosteroids or other 
medications known to affect immune func-
tion (Shade et al. 2004).
Questionnaires and interviews. Information 
on demographics (age, education, income, 
employment status, marital status, and race/
ethnicity), smoking history, and exercise was 
collected via a self-administered questionnaire. 
Body height and weight were measured dur-
ing a clinical exam using a standard protocol. 
Use of multivitamins was determined from an 
in-person interview with each subject where 
supplement labels were photocopied and data 
were abstracted.
Immune measures. All women came to 
the University of Washington Department 
of Laboratory Medicine for blood draws. 
Twelve-hour fasting blood samples were 
taken between 0730 and 0830 hours follow-
ing strict blood-draw criteria described pre-
viously (Boynton et al. 2007). Serum and 
plasma were processed within 1 hr of col-
lection and stored at –70°C. All immune 
assays were conducted at the University of 
Washington Clinical Immunology Laboratory 
in the Department of Laboratory Medicine.
We measured serum CRP and SAA by 
latex-enhanced nephelometry using high- 
sensitivity assays on the Behring Nephelometer 
II analyzer (Dade-Behring Diagnostics, 
Deerfield, IL) with lower detection limits of 
0.2 mg/L for CRP and 0.7 mg/L for SAA. 
The interassay (between-batch) coefficients 
of variation (CVs) were 5–9% for CRP and 
4–8% for SAA.
For serum IL-6, we performed solid-phase 
sandwich enzyme-linked immuno  sorbent 
assays with the Biosource Human IL-6 
Immunoassay kit (Biosource, Camarillo, CA). 
The interassay CVs were < 10% for concen-
trations > 35 pg/mL, and analytical sensitivity 
was 8 pg/mL.
Our method for measuring NK cyto-
toxicity using a flow-cytometric assay has 
been described previously (Shade et al. 2004). 
NK cells were isolated from peripheral blood 
mononuclear cells (PBMCs) obtained from 
14 mL heparin-anticoagulated blood by 
Ficoll-Hypaque separation. We washed and 
diluted cells to a mononuclear cell concentra-
tion of 7.7 × 106 cell/mL.
We prepared K562 target cells as follows:   
We washed cells in the log phase of growth 
twice and incubated them with label 
3,3´-diocta  decyl  oxa  carbocyanine perchlorate 
(DiO; Live/Dead cytotoxicity kit no. L7010; 
Molecular Probes, Eugene, OR). We incu-
bated, washed, and resuspended the cells to 
a concentration of 1 × 106 cells/mL and then 
filtered them through a 35-µm strainer.
We serially diluted the culture-suspended 
NK cells to four effector-to-target cell (E:T) 
ratios of 50:1, 25:1, 12.5:1, and 6.25:1 and 
then pelleted and incubated the cells. We 
added propidium iodide to a final concentra-
tion of 0.03 mg/mL and transferred the cells 
to a polypropylene tube for flow cytometric 
analysis to identify dead cells. We used the 
percentage of dead target cells among a total 
DiO-identified target cells as the measure of 
NK cytotoxicity. We performed each assay 
in duplicate and with appropriate controls. 
Within-run CVs ranged from 5.9% to 8.9%.
We assessed T-lymphocyte prolifera-
tion using cryopreserved PBMCs with two 
methods: 3H-thymidine incorporation in 
response to the mitogen phytohemagglutinin 
(PHA), and the cell-division tracking method 
in response to anti-CD3 antibody. We have 
described these assays previously (Boynton 
et al. 2007). We prepared PBMCs by Ficoll-
Hypaque separation and froze cells in 30% 
fetal calf serum, 60% RPMI medium, and 
10% dimethyl sulfoxide (Gibco, Gaithersburg, 
MD). We included cells from two control 
subjects in every run.
For the 3H-thymidine incorporation, we 
incubated PBMCs in microtiter plates with 
PHA of 0.1 and 0.5 µg/mL in five replicates 
each. After incubation for 3 days at 37°C, we 
pulsed the cells for 24 hr with 3H-thymidine 
and then harvested and counted the cells with 
a β-counter. We express the PHA-stimulated 
lymphocyte proliferation index as counts per 
minute of stimulated cells divided by counts 
per minute of unstimulated cells.
For the cell-division tracking method, we 
added carboxy-fluorescein diacetate succin-
imidyl ester (Molecular Probes), a precursor of 
carboxy-fluorescein succinimidyl ester suspen-
sion at a final concentration of 10 µM. We 
incubated, washed twice, and resuspended the 
cells and then pipetted them into 16 wells of a 
microtiter plate (100,000 cells/well). Next, we 
added anti-CD3 antibody (BD Biosciences, 
San Jose, CA) to eight of the wells to spe-
cifically stimulate T lymphocytes. We used 
the remaining eight wells as control unstimu-
lated cells. After incubation for 3 days at 37°C, 
we pooled identical wells and incubated the 
cells for 3 more days. On the sixth day, we 
Figure 1. Freeways, arterials, and truck routes in the study area (freeway and principal street shapefiles cre­
ated by King County; truck route shapefile created by the City of Seattle) (University of Washington 2007).
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harvested the cells and measured the CFSE–
fluorescein isothiocyanate intensity of viable 
lymphocytes with a flow cytometer (XL-MCL; 
Beckman Coulter, Miami, FL).
We report four variables that quantify 
anti-CD3–stimulated lymphocyte prolifera-
tion measured by the cell-division tracking 
method: a) The proliferation index is the ratio 
of the total number of cells (parent and newly 
proliferated) to the number of back-calculated 
original parent cells; b) the parent percent rep-
resents the percentage of cells in the source cell 
population that did not divide; c) the precur-
sor frequency represents the fraction of cells 
from the source population (i.e., parent cells) 
that divided three or more times; and d) the 
upper generational proliferation index is the 
ratio of the total number of cells (parent and 
newly proliferated from generations three and 
above) to the number of back-calculated origi-
nal parent cells (Boynton et al. 2007).
Geocoding. We geocoded subjects’ resi-
dences at the study baseline using ArcGIS 
software (version 9.0) and StreetMapUSA 
data (2004; both software and data from 
Environmental Systems Research Institute, 
Redlands, CA).
Traffic proxy measures. We obtained 
2005 data on road networks through the 
Washington State Geospatial Data Archive 
(University of Washington 2007). Freeways 
are defined as limited-access highways (Haff 
1993). Arterials are major roads between 
communities, population centers, and facili-
ties. Truck routes are state routes or arterials 
designated by the city of Seattle as accommo-
dating “significant freight movement” (Seattle 
Department of Transportation 2007); these 
data were available only for the city of Seattle. 
Freeway, arterial, and truck route road net-
works are shown in Figure 1.
We measured the distance from the sub-
ject’s residence to the nearest road of each 
particular type using ArcGIS. We computed 
several traffic proxy variables for each road type. 
A dichotomous variable indicated the presence 
of a particular type of road within 150 m of the 
subject’s residence. We chose the distance of 
150 m for the “at-risk” category a priori based 
on findings from previous research that suggest 
that pollutants generated from on-road vehicles 
drop off exponentially with distance from the 
edge of a road, and that these vehicle-generated 
pollutants compose only a small fraction of the 
total pollutants at > 150 m (Zhu et al. 2002). 
However, we experimented with cut points 
of 100 and 200 m for the “at-risk” distance to 
evaluate the sensitivity of our results to the cut 
point chosen. We also created a set of indicator 
variables for categories of increasing residential 
proximity to the nearest road of each particular 
type (categories of > 300–500 m, > 200–300 m, 
> 150–200 m, > 100–150 m, > 50–100 m, and 
0–50 m, with > 500 m as the referent).
Census covariates. We extracted cen-
sus tract variables from the 2000 Census 
Summary File 3 (U.S. Census Bureau 2002), 
including variables describing the racial and 
ethnic composition, unemployment rate, 
median income, education level, housing ten-
ure rate, and population and housing density 
of the residential census tract for each subject.
Statistical analysis. We performed all sta-
tistical analysis using SAS version 9.0 (SAS 
Institute Inc., Cary, NC). Because of skewed 
distributions, we transformed CRP and SAA 
data using the natural logarithm, and IL-6 
using the natural logarithm of the observed 
value plus 0.5.
We used linear regression analysis to inves-
tigate associations between each of the traffic 
proxy metrics and each of the immune out-
comes, adjusting for potential confounding 
factors. We considered CRP, SAA, IL-6, and 
T-lymphocyte proliferation stimulated by PHA 
or anti-CD3 as independent outcomes. We 
considered NK cytotoxicity as a nonindepen-
dent repeated measure in generalized estimating 
equations (GEEs) using the two intermediate 
E:T ratio dilutions: 12.5:1 and 25:1; these two 
dilutions had the greatest reproducibility and 
were in the linear range (Shade et al. 2004). 
For the dichotomous traffic proxy variables 
for residence within 150 m of a particular road 
type, we present model-adjusted least squares 
means and 95% confidence intervals (CIs) 
for each category, generated from the lsmeans 
statement of Proc GENMOD in SAS.
We selected variables a priori for adjust-
ment as potential confounders, including age, 
BMI, education (individual-level), season of 
enrollment, time spent outdoors, and median 
income in the census tract of residence. We 
investigated associations of the traffic proxies 
with the immune outcomes among several 
pairs or trios of subgroup strata: a) overweight 
(BMI < 30) versus obese (BMI ≥ 30) subjects; 
b) low (< $35,000) versus middle ($35,000 
to $75,000) versus high (> $75,000) income; 
and c) subjects reporting an hour or more of 
exercise near traffic versus subjects report-
ing no exercise near traffic in the previous 
3 months on the baseline questionnaire.
Results
Study population. The 115 women in the 
study were highly educated, mostly non-
Hispanic white, with high BMI; almost half 
the study population was classified as obese 
(BMI ≥ 30 kg/m2) (Table 1); 27% (n = 31) of 
women in the study lived near (within 150 m) 
major arterials, 3% (n = 3) lived near freeways, 
Table 1. Study population characteristics.
  All subjects  Not near arteriala  Near arteriala
Characteristic  (n = 115)  (n = 84)  (n = 31)  p-Valueb
Age, years [no. (%)] 
  50–55  33 (29)  23 (27)  10 (32)  0.38
  56–60  33 (29)  24 (29)  9 (29)
  61–65  16 (14)  13 (15)  3 (10)
  66–70  16 (14)  14 (17)  2 (6)
  71–75  17 (15)  10 (12)  7 (23)
  Mean ± SD  60.7 ± 6.8  60.6 ± 6.7  61.1 ± 7.3  0.55
BMI [no. (%)]
  24 to < 30  63 (55)  46 (55)  17 (55)  0.99
  30 to < 35  37 (32)  27 (32)  10 (32)
  ≥ 35  15 (13)  11 (13)  4 (13)
  Mean ± SD  30.3 ± 3.9  30.3 ± 3.9  30.2 ± 3.9  0.95
Race [no. (%)]c
  White (not of Hispanic origin)  101 (89)  75 (90)  26 (84)  0.33
  Nonwhite  13 (11)  8 (10)  5 (16)
Education [no. (%)] 
  High school or less  17 (15)  13 (15)  4 (13)  0.54
  Some college or college degree  57 (50)  39 (46)  18 (58)
  Graduate degree  41 (36)  32 (38)  9 (29)
Season of enrollment [no. (%)]
  Winter  23 (20)  18 (21)  6 (19)  0.96
  Spring  44 (38)  31 (37)  12 (39)
  Summer  23 (20)  16 (19)  7 (23)
  Fall  25 (22)  19 (23)  6 (19)
Time spent outdoors [no. (%)]c
  0–1 hr/week  17 (15)  13 (15)  4 (13)  0.97
  2 hr/week  24 (21)  18 (21)  6 (19)
  3–5 hr/week  29 (25)  21 (25)  8 (26)
  6 or more hr/week  45 (39)  32 (38)  13 (42)
Median income of the census tract  $58 ± $18  $62 ± $19  $50 ± $14  0.04
  of residence (mean ± SD × 1,000)
a“Near arterial”: an arterial road was located within 150 m of a woman’s residence. bFor continuous variables, the p­value 
is from a t­test (assuming equal variances) comparing the variable values between those living near arterials and those not 
living near arterials; for categorical variables, the p­value is from a Pearson chi­square test of independence. cNumbers 
not equal to total because of missing data.Williams et al.
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and 15% (n = 9) of the 61 residents of Seattle, 
where truck routes were assessed, lived near 
designated truck routes. Women who lived 
near arterials were more likely to be younger, 
nonwhite, and less educated than those who 
did not and were more likely to live in cen-
sus tracts in which the median income was 
lower; however, only the difference in census 
tract–level income was statistically significant 
(Table 1). Women who lived near arterials 
reported similar amounts of time spent out-
doors compared with women who did not live 
near arterials. Table 2 shows the distribution 
of each immune outcome and the number of 
subjects with data for inclusion in analyses. 
We did not have adequate power to assess the 
effect of living near freeways, because only 
three subjects lived within 150 m of a freeway 
(data not shown).
We observed a statistically significant asso-
ciation, in our hypothesized direction of effect, 
between residence near arterials and NK cyto-
toxicity, within our a priori hypothesized at-
risk group of women living within 150 m of 
major roads (Table 3). Those who lived near 
arterials had, on average, NK cyto  toxicity 
(expressed as the percentage of cells killed) of 
19.5% (95% CI, 15.6–23.4%), compared 
with 24.8% (95% CI, 22.0–27.5%) among 
those who did not live near arterials. NK cyto-
toxicity was also lower among those living 
near truck routes than among those who did 
not, although this was not significant at a two-
sided α level of 0.05. These associations were 
not sensitive to our a priori choice of covari-
ates for adjustment of potential confound-
ing; for example, models without inclusion of 
the covariates generated similar estimates for 
the mean NK cytotoxicity among those living 
near arterials (19.3%; 95% CI, 15.5–23.0%) 
and those living farther away (24.8%; 95% 
CI, 22.1–27.6%). The association between 
NK cytotoxicity and living near arterials was 
limited to those women who reported exercis-
ing near traffic (Table 4) or among women 
in the middle group of individual income 
($35,000 to $75,000) (data not shown).
We observed significant associations of 
NK cytotoxicity with living near arterials 
when using alternate cut points of either 100 
or 200 m for our definition of proximity to 
traffic, and the magnitudes of the associations 
were similar to our main analysis, indicating 
that this result was not excessively sensitive to 
our a priori cut point of 150 m. Residential 
proximity to truck routes was not significantly 
associated with NK cytotoxicity in the analy-
sis using 100 m as the alternate cut point, and 
the association was strongest when using the 
cut point of 200 m. Estimated NK cytotoxic-
ity was 15.5% among women living within 
200 m of truck routes compared with 26.2% 
among women living at greater distances, 
and this difference was highly significant (p = 
0.0009; data not shown). 
There were no trends of association with 
increasing proximity to major roads for 
either road type, in models including indi-
cator variables for categories of distance 
from a major road compared with a refer-
ence category of > 500 m [Supplemental 
Material, Table 1 (http://www.ehponline.
org/  members/2008/11580/suppl.pdf)]. 
We observed no associations between the 
markers of inflammation (CRP, SAA, IL-6) 
or PHA-stimulated lymphocyte proliferation 
and the traffic proxy variables (Table 5). We 
noted a significantly lower average upper gen-
erational proliferation index—one of the four 
measures of anti-CD3–stimulated lympho-
cyte proliferation—associated with residence 
near major arterials (Table 5). The other three 
measures of anti-CD3–stimulated lympho-
cyte proliferation were not associated with 
residence near arterials (Table 5), nor was 
residence near truck routes associated with 
any of the anti-CD3–stimulated lymphocyte 
proliferation measures (data not shown).
Discussion
Ours is the first study, to our knowledge, 
of the association of traffic proxy measures 
and functional assays of cellular immunity. 
We observed an internally consistent asso-
ciation between residence within 150 m of 
major arterials or truck routes and lower NK 
cytotoxicity. The association was limited to 
those who reported exercising outdoors near 
traffic—individuals who presumably had 
higher exposure to traffic-related pollutants. 
We also found an association of living near 
arterials with lower than average lymphocyte 
prolifera  tion; however, this result was not 
internally consistent among the various traffic 
proxy variables or lymphocyte proliferation 
meas  ures, and we therefore consider the asso-
ciation tenuous. We observed no association 
between the traffic proxies and inflammation 
markers. In our modest-sized study, we ana-
lyzed five assays of immune status and several 
traffic proxy variables; therefore, our statisti-
cally significant results should be cautiously 
interpreted with respect to the possibility of 
chance findings and according to the consis-
tency and robustness of the results.
NK cells are involved in the innate 
immune response and can destroy virally 
infected and transformed cells (Janeway et al. 
2005). Although the relationship between 
in vivo NK function and NK cytotoxicity is 
unclear, low NK cytotoxicity has been associ-
ated with increased risk of infection, increased 
cancer risk, and increased risk of death 
among cancer survivors and institutionalized 
elderly (Albers et al. 2005; Imai et al. 2000; 
Kondo et al. 2003; Levy et al. 1991; Ogata 
et al. 2001). Researchers have found some 
Table 2. Immune biomarker distributions in the study population.
Biomarker  No.a  Mean ± SD  Minimum  Maximum
Inflammation markers
  CRP (mg/L)  114  3.7 ± 3.5  0.2  23.3
  SAA (mg/L)  114  6.2 ± 5.5  1.4  43.0
  IL-6 (pg/mL)  115  3.3 ± 3.1  0  20.0
NK cytotoxicity (%)
  25:1 E:T ratio  114  26.9 ± 13.3  4.35  68.9
  12.5:1 E:T ratio   114  19.8 ± 12.0  3.15  59.6
PHA-stimulated lymphocyte proliferation
  Proliferation indexb—PHA 0.1 µg/mL  110  76.8 ± 47.5  2.1  209.5
  Proliferation indexb—PHA 0.5 µg/mL  110  207.3 ± 95.9  2.4  457.4
Anti-CD3–stimulated lymphocyte proliferation
  Proliferation indexc  93  4.9 ± 2.0  1.3  11.8
  Precursor frequencyd  93  0.3 ± 0.1  0.02  0.5
  Parent percent (%)e  93  15.0 ± 11.7  4.4  71.9
  Upper generation proliferation indexf  93  15.3 ± 5.2  7.3  31.7
aThe number of women with nonmissing data for each assay is shown. bCounts per minute of stimulated cells/counts per 
minute of unstimulated cells. cTotal number of cells (parent and newly proliferated) divided by the number of back­calcu­
lated original parent cells.dFraction of cells from the source population (i.e., parent cells) that divided three or more times. 
ePercentage of cells in the source cell population that did not divide. fTotal number of cells (parent and newly proliferated 
from generations three and above) divided by the number of back­calculated original parent cells.
Table 3. NK cytotoxicity by residence near (within 
150 m) different major road types.
      NK cytotoxicity (%)
Residence  No.   [mean (95% CI)]
Residence near arterial
  No  84  24.8 (22.0–27.5)
  Yes  30  19.5 (15.6–23.4)
  Difference between means     p = 0.047
Residence near truck routea
  No  51  25.5 (22.1–28.9)
  Yes  9   17.0 (10.9–23.1)
  Difference between means     p = 0.06
For each major road type, we present model­adjusted 
least squares means of NK cytotoxicity at 12.5:1 and 25:1 
E:T ratios generated from the lsmeans statement in proc 
GENMOD using a generalized estimating equation regres­
sion, while accounting for within­person correlation. The 
p­values represent an analysis of variance test of the 
difference between means. Estimates are adjusted for 
covariates selected a priori: age, BMI, education, blood 
draw season, time spent outdoors, and median income of 
residential census tract. 
aTruck routes were classified only for the City of Seattle, 
where 61 women lived, and 60 of these women had non­
missing data for NK cytotoxicity.Traffic and immune status
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evidence of associations between air pollution 
from traffic and infections (Brauer et al. 2002, 
2006, 2007; Fusco et al. 2001; Lin et al. 2005; 
Morgenstern et al. 2007; U.S. EPA 2002), 
and associations between air pollution and NK 
cytotoxicity would strengthen the evidence for 
this important clinical outcome by suggesting 
a potential underlying biologic mechanism. 
The studies relating measures of ambient or 
traffic-related air pollution to colds and other 
infections have been conducted mostly among 
young children, and further research among 
older adults is needed to understand the pos-
sible health implications of the association we 
observed between reduced NK cytotoxicity 
and proximity to traffic.
In contrast to our results for NK cyto-
toxicity, we observed no consistent associa-
tions between traffic proxies and lymphocyte 
proliferation measures. As a predictor, lower 
in vitro lymphocyte proliferation has been 
found to be correlated with worse HIV prog-
nosis (Hofmann et al. 1989; Schellekens et al. 
1990), and we would expect that a human 
whose lymphocytes experience a decreased 
ability to proliferate upon stimulation would 
have increased vulnerability to infection. 
Nevertheless, it is not known whether an 
increased proliferative response in the in vitro 
lymphocyte proliferation assay corresponds 
with a more effective physiologic immune 
response (Vedhara et al. 1999). Measures from 
lymphocyte proliferation assays have proven 
to be less sensitive than NK cyto  toxicity assays 
in nutrition intervention studies, indicating 
potentially lower sensitivity of lymphocyte 
proliferation to detect in vivo effects from 
external exposures (Albers et al. 2005).
On the basis of previous studies, we 
hypothesized an association between proximity 
to traffic and increased levels of CRP. About 
half of the previous studies of air pollution and 
CRP have observed associations between CRP 
and at least one measure of air pollution (usu-
ally a specific pollutant, e.g., fine or coarse PM) 
(Delfino et al. 2008; Diez Roux et al. 2006; 
Dubowsky et al. 2006; Peters et al. 2001; Pope 
et al. 2004; Riediker et al. 2004; Ruckerl et al. 
2006; Seaton et al. 1999; Yue et al. 2007; Zeka 
et al. 2006); the prior evidence for associations 
of specific air pollutants with other inflamma-
tion markers, such as SAA or IL-6, is limited 
and conflicting (Delfino et al. 2008; Diez Roux 
et al. 2006; Frampton et al. 2004; Ghio et al. 
2003; Gong et al. 2003; Seaton et al. 1999). 
There are several differences between our 
exposure metric and the studies that found an 
association with CRP. In the previous studies, 
higher CRP levels were associated with air pol-
lution levels during a very recent time period 
such as the same day or preceding 1–9 days. 
Our exposure metric reflects an average expo-
sure to local traffic-related pollutants in which 
short-term fluctuations due to background 
urban air pollution or personal exposures are 
not captured. It is possible that CRP levels 
(and other inflammatory markers) change in 
response to recent exposures in the preced-
ing days or weeks, in which case our metric 
of average exposure would not be appropriate 
for modeling the association. Second, proxim-
ity to major roads represents the potential for 
mixed pollutant exposure from traffic. If the 
inflammatory response is specific to a certain 
pollutant such as PM, then the nonspecific-
ity of our exposure metric may have obscured 
any association.
The strengths of this study include the 
objective outcome assessment using bio-
markers, the strict criteria for blood draws, 
use of state-of-the-art assays for characterizing 
immune function, objective exposure assess-
ment using a geographic information sys-
tem (GIS), and the homogeneity of the study 
population. Our study also had several limi-
tations. Although assigning exposure based 
on proximity to major roads is a straight-
forward approach to evaluating exposure to 
a pollution source, it is not as sophisticated 
as other approaches such as dispersion mod-
eling. Measurement campaigns have indi-
cated that although proximity measures 
are correlated with traffic pollutants, mis-
classification occurs due to varying terrain 
and meteorologic conditions (Jerrett et al. 
2005); therefore, our traffic proxies are sub-
ject to misclassification that may have caused 
spurious results. The proximity metric we 
employed may also be more vulnerable to 
confounding by socioeconomic factors or 
traffic-related noise than would more specific 
air pollutant exposure models. Nevertheless, 
adjustment for multiple individual-level and 
census tract–level socioeconomic variables 
did not change the associations we observed.
In this article, we report an association 
between residential proximity to traffic and 
an important in vitro marker of cellular 
Table 5. Inflammation and lymphocyte proliferation measures by residence near (within 150 m) arterial 
road (estimated mean and 95% CIs).
  Near arterial  Difference
Measure  No (n = 84)a  Yes (n = 31)  between means
Inflammation markers  n = 83  n = 31 
  CRP (mg/mL)  2.5 (2.1–3.0)  2.3 (1.6–3.1)  p = 0.62
  IL-6 (pg/mL)b  2.4 (2.0–2.9)  2.1 (1.5–2.9)  p = 0.51
  SAA (mg/mL)  4.9 (4.3–5.5)  5.3 (4.3–6.6)  p = 0.52
PHA-stimulated lymphocyte proliferation  n = 80  n = 30 
  Proliferation indexc—PHA 0.1 µg/mL  75.2 (64.7–85.8)  81.2 (63.6–98.7)  p = 0.57
  Proliferation indexc—PHA 0.5 µg/mL  206.9 (185.0–228.8)  208.4 (172.0–244.9)  p = 0.94
Anti-CD3–stimulated lymphocyte proliferation  n = 66  n = 27 
  Proliferation indexd  4.9 (4.4–5.4)  4.7 (4.0–5.5)  p = 0.68
  Parent percente  17.3 (14.3–20.3)  16.2 (11.5–21.0)  p = 0.71
  Precursor frequencyf  0.26 (0.23–0.28)  0.28 (0.24–0.32)  p = 0.32
  Upper generation proliferation indexg  16.0 (14.8–17.2)  13.5 (11.7–15.5)  p = 0.04
For each major road type, we present model­adjusted least squares means of each immune measure generated fom the 
lsmeans statement in proc GENMOD. The p­values represent an analysis of variance test of the difference between means. 
Estimates are adjusted for covariates selected a priori: age, BMI, education, blood draw season, time spent outdoors, and 
median income of residential census tract. 
aNumbers reflect the distribution of the complete study population of 115 women; the number of women with nonmissing data 
for each assay varies, as shown. bThere were no missing data for the IL­6 assay; n = 115. cCounts per minute of stimulated 
cells/counts per minute of unstimulated cells. dTotal number of cells (parent and newly proliferated) divided by the number of 
back­calculated original parent cells. ePercentage of cells in the source cell population that did not divide. fFraction of cells 
from the source population (i.e., parent cells) that divided three or more times. gTotal number of cells (parent and newly 
proliferated from generations three and above) divided by the number of back­calculated original parent cells.
Table 4. NK cytotoxicity by residence near (within 150 m) different major road types and exercise near traffic.
   NK cytotoxicity (%)
  No exercise near traffic  Any exercise near traffic 
Residence  No.  Mean  (95% CI)  No.  Mean  (95% CI)
Near arteriala              
  No  51  21.4  (18.6–24.1)  26  28.8  (23.8–33.8)
  Yes  11  21.0  (13.6–28.5)  15  20.7  (14.8–26.4)
  Difference between means  p = 0.93  p = 0.08
Near truck routea              
  No  23  21.1  (17.7–24.4)  22  29.7  (26.0–33.4)
  Yes  3  24.6  (13.1–36.1)  6  10.2  (2.9–17.5)
  Difference between means  p = 0.58  p < 0.01
For each major road type, we present model­adjusted least squares means of NK cytotoxicity at 12.5:1 and 25:1 E:T ratios 
generated from the lsmeans statement in proc GENMOD using a generalized estimating equation regression, while 
accounting for within­person correlation. The p­values represent an analysis of variance test of the difference between 
means. Estimates are adjusted for covariates selected a priori: age, BMI, education, blood draw season, time spent out­
doors, and median income of residential census tract. 
aNonmissing data on both NK cytotoxicity and exercise near traffic were available for 103 women in the study area, and 
for 54 women in the City of Seattle where truck routes were assessed. Williams et al.
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immunity. Our study population was selected 
to be overweight or obese, but otherwise 
healthy. Approximately two-thirds of U.S. 
women in the age group we studied fall into 
this category (Mokdad et al. 2003; Ogden 
et al. 2006), and if the associations we 
observed are true, they would be relevant for a 
large proportion of the population. Additional 
studies of clinically relevant immune events 
such as infections and colds in relation to 
traffic-related pollution are needed to clarify 
the impact of traffic on the immune system 
and inform local land use policy.
co r r e c t i o n
The values for the two rows “Proliferation 
index—PHA” in Table 5 were incorrect in 
the manuscript originally published online. 
They have been corrected here.
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